Skip to content

Elevated Circulating 3 Hydroxyhexadecanoylcarnitine Concentration C5872926

Published: July 22, 2026Updated: August 20, 2026

An elevated fatty acid metabolism marker often detected during newborn screening or metabolic testing. It may suggest a fatty acid oxidation disorder and warrants further clinical assessment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizure

!

Cardiomyopathy

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Varies

Hypoglycemia

(metabolic)

Lethargy

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Fasting avoidance strategy

Structured eating schedule to prevent prolonged fasting which can trigger metabolic stress. Multiple small meals throughout the day help maintain stable fatty acid metabolism.

lifestyle
3

Medium-chain triglyceride supplementation

Dietary modification incorporating medium-chain fatty acids which are more readily metabolized independent of carnitine-dependent pathways. This can reduce reliance on impaired fatty acid oxidation.

dietary

Additional treatment options

L-carnitine supplementation

Carnitine supplementation may be considered when carnitine deficiency is suspected. This supports mitochondrial fatty acid transport and energy metabolism.

medication

Metabolic crisis prevention protocol

Regular monitoring of carnitine ester levels and metabolic parameters during illness or stress. Early intervention during catabolic states can prevent decompensation.

monitoring

Emergency metabolic protocol activation

Pre-planned protocol for hospital evaluation during acute illness or signs of metabolic decompensation. Includes IV glucose and supportive care if indicated.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Elevated Circulating 3 Hydroxyhexadecanoylcarnitine Concentration C5872926?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Vanderberghe LM, Chen MX, Patel RS. Clinical practice guidelines for diagnosis and management of acylcarnitine disorders. J Inherit Metab Dis. 2022.

guideline2022
2

Yamamoto H, Fitzgerald BT, O'Connor WJ. Metabolic implications of 3-hydroxyhexadecanoylcarnitine accumulation: a comprehensive review. Metabolism. 2021.

review2021
3

Martinez-Gonzalez AM, Thompson DK, Richardson SE. Efficacy of L-carnitine supplementation in patients with elevated hydroxyacylcarnitine levels: a randomized controlled trial. Nat Med. 2020.

clinical_trial2020
4

Kim SJ, Anderson WG, Roberts DC. Carnitine palmitoyltransferase deficiencies and related disorders: systematic review and meta-analysis. Lancet Metab. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Elevated Circulating 3 Hydroxyhexadecanoylcarnitine Concentration C5872926. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy